Cellular Biomedicine: 3Q Earnings Snapshot
CUPERTINO, Calif. (AP) _ Cellular Biomedicine Group Inc. (CBMG) on Tuesday reported a loss of $12.7 million in its third quarter.
On a per-share basis, the Cupertino, California-based company said it had a loss of 72 cents. Losses, adjusted for non-recurring costs, came to 56 cents per share.
The biotechnology company posted revenue of $70,400 in the period. Its adjusted revenue was $70,000.
Cellular Biomedicine shares have climbed 26 percent since the beginning of the year. The stock has risen 32 percent in the last 12 months.